NVIDIA and ConcertAI Join Forces to Develop AI Agents for Enhanced Oncology Trial Solutions
In 2025, ConcertAI is making waves in oncology by partnering with NVIDIA to integrate advanced AI agents into clinical workflows. These AI agents, which include various language models, streamline the analysis of vast amounts of patient data to improve clinical trial designs. CEO Jeff Elton emphasizes the importance of maintaining data integrity while ensuring that ...
